1. Personal health records as portal to the electronic medical record

   • Jennifer E. Cahill
   • Mark R. Gilbert
   • Terri S. Armstrong

   Topic Review 30 January 2014 Pages: 1 - 6

2. PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

   • Parvin F. Peddi
   • Sara A. Hurvitz

   Topic Review 28 January 2014 Pages: 7 - 13

   

3. Detection of primary cilia in human glioblastoma

   • Matthew R. Sarkisian
   • Dorit Siebzehnrubl
   • Brent A. Reynolds

   Laboratory Investigation 09 February 2014 Pages: 15 - 24

   

4. NDRG1 prognosticates the natural course of disease in WHO grade II glioma

   • J. Blaes
   • M. Weiler
   • W. Wick

   Laboratory Investigation 07 January 2014 Pages: 25 - 32

   

5. Radiologic and histologic consequences of radiosurgery for brain tumors

   • Ahmed Alomari
   • Philipp J. Rauch
   • Alexander O. Vortmeyer

   Laboratory Investigation 18 January 2014 Pages: 33 - 42

   

6. CXCL12 secreted from glioma stem cells regulates their proliferation

   • Youji Uemae
   • Eiichi Ishikawa
   • Akira Matsumura

   Laboratory Investigation 19 January 2014 Pages: 43 - 51

   

7. C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma

   • Nuraly K. Avliyakulov
   • Kavitha S. Rajavel
   • Whitney B. Pope

   Laboratory Investigation 29 January 2014 Pages: 53 - 65

   

8. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas

   • Kathleen Dorris
   • Matthew Sobo
   • Rachid Drissi

   Laboratory Investigation 30 January 2014 Pages: 67 - 76

   

9. Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation

   • Laia Capdevila
   • Sara Cros
   • Carmen Balañà

   Clinical Study 07 January 2014 Pages: 77 - 84

   

10. Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma

    • Benedikt Wiestler
    • Alexander Radbruch
    • Antje Wick

    Clinical Study 24 January 2014 Pages: 85 - 92

    

11. A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas

    • Jeffrey J. Raizer
    • Sean A. Grimm
    • Marc Chamberlain

    Clinical Study 22 January 2014 Pages: 93 - 101

    

12. Patterns of care at end of life for people with primary intracranial tumors: lessons learned

    • Abdulrahman Alturki
    • Bruno Gagnon
    • Nancy Mayo

    Clinical Study 28 January 2014 Pages: 103 - 115

    

13. CSF CA 15-3 in breast cancer-related leptomeningeal metastases

    • Emilie Le Rhun
    • Andrew Kramar
    • Marc C. Chamberlain

    Clinical Study 28 January 2014 Pages: 117 - 124

    

14. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

    • Colin E. Champ
    • Joshua D. Palmer
    • Wenyin Shi

    Clinical Study 19 January 2014 Pages: 125 - 131

    

15. Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab

    • William Magnuson
    • H. Ian Robins
    • Steven Howard

    Clinical Study 28 January 2014 Pages: 133 - 139

    

16. Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

    • Günter Eisele
    • Antje Wick
    • Michael Weller

    Clinical Study 19 January 2014 Pages: 141 - 145

17. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression

    • Mairéad G. McNamara
    • Zarnie Lwin
    • Warren P. Mason

    Clinical Study 28 January 2014 Pages: 147 - 152

    

18. Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era

    • Mairéad G. McNamara
    • Zarnie Lwin
    • Warren P. Mason

    Clinical Study 29 January 2014 Pages: 153 - 160

    

19. Methotrexate re-challenge for recurrent primary central nervous system lymphoma

    • Elena Pentsova
    • Lisa M. DeAngelis
    • Antonio Omuro

    Clinical Study 31 January 2014 Pages: 161 - 165

    

20. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?

    • Jeremy M. Kilburn
    • Thomas L. Ellis
    • Michael D. Chan

    Clinical Study 07 February 2014 Pages: 167 - 174

    

21. Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma

    • Robert M. Lober
    • Yoon-Jae Cho
    • Kristen W. Yeom

    Clinical Study 13 February 2014 Pages: 175 - 182

    

22. High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas

    • Kimmo J. Hatanpaa
    • Tianshen Hu
    • Robert M. Bachoo

    Clinical Study 12 February 2014 Pages: 183 - 189

    

23. Detecting post-surgical recurrence in a patient with Cushing’s disease

    • Kelley J. Moloney
    • Jennifer U. Mercado
    • Marc R. Mayberg

    Letter to the Editor Open access 12 February 2014 Pages: 191 - 193

    

24. The Neutrophil Lymphocyte Ratio in Patients with Glioblastoma Multiforme

    • Sevket Balta
    • Sait Demirkol
    • Cengiz Ozturk

    Letter to the Editor 10 January 2014 Pages: 195 - 196